Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 43% ± 24% | |
placental villous trophoblast | 3 studies | 91% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
placenta | 3 studies | 47% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2837.33 | 244 / 245 | 89% | 21.17 | 447 / 502 |
uterus | 91% | 295.44 | 155 / 170 | 7% | 1.77 | 30 / 459 |
muscle | 85% | 40.87 | 679 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 72% | 26.00 | 186 / 258 | 3% | 0.24 | 7 / 230 |
ovary | 42% | 59.94 | 76 / 180 | 4% | 0.48 | 18 / 430 |
esophagus | 34% | 20.76 | 492 / 1445 | 3% | 0.36 | 5 / 183 |
liver | 2% | 0.45 | 4 / 226 | 26% | 32.72 | 106 / 406 |
kidney | 20% | 14.01 | 18 / 89 | 0% | 0.06 | 4 / 901 |
spleen | 11% | 1.73 | 26 / 241 | 0% | 0 | 0 / 0 |
brain | 11% | 2.80 | 280 / 2642 | 0% | 0 | 0 / 705 |
stomach | 9% | 2.96 | 31 / 359 | 2% | 1.15 | 5 / 286 |
adipose | 7% | 2.40 | 84 / 1204 | 0% | 0 | 0 / 0 |
lung | 3% | 0.42 | 15 / 578 | 3% | 0.38 | 31 / 1155 |
breast | 3% | 0.98 | 13 / 459 | 0% | 0.05 | 4 / 1118 |
intestine | 2% | 0.89 | 24 / 966 | 1% | 0.02 | 3 / 527 |
skin | 0% | 0.12 | 8 / 1809 | 0% | 0.03 | 2 / 472 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.19 | 4 / 504 |
thymus | 0% | 0.07 | 3 / 653 | 0% | 0 | 0 / 605 |
blood vessel | 0% | 0.11 | 5 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.08 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1903427 | Biological process | negative regulation of reactive oxygen species biosynthetic process |
GO_0032872 | Biological process | regulation of stress-activated MAPK cascade |
GO_0042594 | Biological process | response to starvation |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | PAGE4 |
Protein name | P antigen family member 4 (PAGE-4) (G antigen family C member 1) (PAGE-1) |
Synonyms | JM27 GAGEC1 |
Description | FUNCTION: Intrinsically disordered protein that potentiates the transcriptional activator activity of JUN . Protects cells from stress-induced apoptosis by inhibiting reactive oxygen species (ROS) production and via regulation of the MAPK signaling pathway . . |
Accessions | ENST00000218068.7 ENST00000376141.5 O60829 |